Alcohol intoxication elevates subjective sleepiness and disrupts sleep objectively in women more than in men, regardless of family history of alcoholism, according to a study published online Feb. 15 in Alcoholism: Clinical & Experimental Research.
FRIDAY, Feb. 18 (HealthDay News) -- Alcohol intoxication elevates subjective sleepiness and disrupts sleep objectively in women more than in men, regardless of family history of alcoholism, according to a study published online Feb. 15 in Alcoholism: Clinical & Experimental Research.
J. Todd Arnedt, Ph.D., from the University of Michigan in Ann Arbor, and colleagues studied 93 healthy young adults to evaluate sex and family history of alcoholism as moderators of subjective ratings of sleepiness/sleep quality following alcohol intoxication. Participants included 59 women, and 29 subjects with a family history of alcoholism. Participants consumed alcohol to intoxication, or matching placebo, then had their sleep monitored using polysomnography. Sleep ratings were completed at bedtime and on awakening.
The researchers found that, after alcohol, women experience more disrupted total sleep time, sleep efficiency, nighttime awakenings, and wake after sleep onset, regardless of family history. Compared to the placebo, alcohol reduced sleep onset latency, sleep efficiency, and rapid eye movement sleep, and increased wakefulness and slow wave sleep during the entire night. After alcohol, sleepiness ratings were elevated, especially for women at bedtime, and morning sleep-quality ratings were reduced.
"Sleep disturbances were more evident in women than in men at an equally high peak breath alcohol concentration, but subjective ratings did not differ between sexes and only partially reflected the increased sleep disruption induced by alcohol. Sleep among those with a family history of alcoholism did not differ from family-history-negative subjects following alcohol consumption," the authors write.
AbstractFull Text (subscription or payment may be required)
Related Content
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More